Invitation offering the opportunity to consider taking part in a clinical study looking at a new medicine for Insomnia

Posted on December 19th, 2023

RESTORE is an Insomnia study based on whether the short term treatment of Chloral Hydrate is effective in patients with severe insomnia.

Persistent insomnia affects approximately 10% of the adult population and is a risk factor for several mental and physical health problems, particularly depression and cardiometabolic disease. The primary aim of this trial is to establish in a real world setting, whether short-term treatment of Chloral Hydrate is effective in patients with severe insomnia which is interfering with normal daily life and where other therapies (behavioural and pharmacologic) have failed. Secondary objectives will assess safety, tolerability, identification of baseline characteristics, changes in quality of life and self-reported sleep, within a real-world setting.

A selection of our eligible patients will be invited to consider taking part. It is a decentralised clinical trial, so patients are screened completely online remotely by the study centre staff and do not need to physically travel to any centres or clinics.